Abstract
New approaches to drug safety are yielding dividends in the United States and Europe, while legislation to introduce tougher new regulations in Canada continue to languish, delegates to the seventh annual Canadian Drug Information Association conference in Ottawa, Ontario, were told Nov. 4. The US
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
